During the past decade, Centro Comprensivo de Cancer de UPR conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 5 clinical trials were completed, i.e. on average, 16.1% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 5 clinical trials were completed. i.e. 35.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Comprensivo de Cancer de UPR" #1 sponsor was "National Cancer Institute (NCI)" with 16 trials, followed by "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored, "NRG Oncology" with 4 trials sponsored, "Alliance for Clinical Trials in Oncology" with 3 trials sponsored and "SWOG Cancer Research Network" with 3 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Comprensivo de Cancer de UPR" #1 collaborator was "National Cancer Institute (NCI)" with 19 trials as a collaborator, "NRG Oncology" with 9 trials as a collaborator, "Canadian Cancer Trials Group" with 5 trials as a collaborator, "AIDS and Cancer Specimen Resource" with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Centro Comprensivo de Cancer de UPR" are "Malignant Solid Neoplasm" (3 trials), "Ovarian Seromucinous Carcinoma" (3 trials), "Recurrent Ovarian Carcinoma" (3 trials), "Anal Cancer" (2 trials) and "Colon Adenocarcinoma" (2 trials). Many other conditions were trialed in "Centro Comprensivo de Cancer de UPR" in a lesser frequency.

Most popular intervention types in "Centro Comprensivo de Cancer de UPR" are "Other" (26 trials), "Drug" (24 trials), "Procedure" (17 trials), "Biological" (11 trials) and "Radiation" (7 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (10 trials), "Questionnaire Administration" (8 trials), "Biospecimen Collection" (7 trials), "Computed Tomography" (7 trials) and "Laboratory Biomarker Analysis" (7 trials). Other intervention names were less common.

The vast majority of trials in "Centro Comprensivo de Cancer de UPR" are 22 trials for "All" genders, 10 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Centro Comprensivo de Cancer de UPR". undefined are not yet recruiting, 14 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Centro Comprensivo de Cancer de UPR, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Comprensivo de Cancer de UPR, 1 "Phase 1" clinical trials were conducted, 18 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".